PPAR Alpha (LY518674): A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia
PPAR Alpha (LY518674): A Phase 2 Study of the Combinatorial Effect of LY518674 and Atorvastatin in Subjects With Hypercholesterolemia
The purposes of this study are to determine:
Inclusion Criteria:
Exclusion Criteria:
Fayetteville, Arkansas 72703, United States
Stockton, California 95204, United States
Highlands Ranch, Colorado 80130, United States
Brandon, Florida 33511, United States
Kissimmee, Florida 34741, United States
Longwood, Florida 32779, United States
Oviedo, Florida 32765, United States
Chicago, Illinois 60607, United States
Kansas City, Kansas 66160, United States
Wichita, Kansas 67208, United States
Lexington, Kentucky 40504, United States
Auburn, Maine 04210, United States
Rockville, Maryland 20854, United States
Benzonia, Michigan 49616, United States
Cadillac, Michigan 49601, United States
Interlochen, Michigan 49643, United States
Excelsior Springs, Missouri 64024, United States
Charlotte, North Carolina 28262, United States
Greensboro, North Carolina 27401, United States
Raleigh, North Carolina 27609, United States
Wilmington, North Carolina 28412, United States
Winston-Salem, North Carolina 27103, United States
Mansfield, Ohio 44903, United States
Portland, Oregon 97225, United States
Philadelphia, Pennsylvania 19115, United States
Stoneboro, Pennsylvania 16153, United States
Bristol, Tennessee 37620, United States